These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30086172)

  • 1. Searching for novel biomarkers using a mouse model of CLN3-Batten disease.
    Timm D; Cain JT; Geraets RD; White KA; Koh SY; Kielian T; Pearce DA; Hastings ML; Weimer JM
    PLoS One; 2018; 13(8):e0201470. PubMed ID: 30086172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.
    Osório NS; Sampaio-Marques B; Chan CH; Oliveira P; Pearce DA; Sousa N; Rodrigues F
    Genes Brain Behav; 2009 Apr; 8(3):337-45. PubMed ID: 19243453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.
    Kovács AD; Pearce DA
    Dis Model Mech; 2015 Apr; 8(4):351-61. PubMed ID: 26035843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes.
    Swier VJ; White KA; Johnson TB; Wang X; Han J; Pearce DA; Singh R; Drack AV; Pfeifer W; Rogers CS; Brudvig JJ; Weimer JM
    Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37305926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
    Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
    Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease.
    Pontikis CC; Cotman SL; MacDonald ME; Cooper JD
    Neurobiol Dis; 2005 Dec; 20(3):823-36. PubMed ID: 16006136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.
    Kleine Holthaus SM; Aristorena M; Maswood R; Semenyuk O; Hoke J; Hare A; Smith AJ; Mole SE; Ali RR
    Hum Gene Ther; 2020 Jul; 31(13-14):709-718. PubMed ID: 32578444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.
    Centa JL; Jodelka FM; Hinrich AJ; Johnson TB; Ochaba J; Jackson M; Duelli DM; Weimer JM; Rigo F; Hastings ML
    Nat Med; 2020 Sep; 26(9):1444-1451. PubMed ID: 32719489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).
    Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T
    Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).
    Burkovetskaya M; Karpuk N; Xiong J; Bosch M; Boska MD; Takeuchi H; Suzumura A; Kielian T
    PLoS One; 2014; 9(4):e95023. PubMed ID: 24736558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A knock-in reporter model of Batten disease.
    Eliason SL; Stein CS; Mao Q; Tecedor L; Ding SL; Gaines DM; Davidson BL
    J Neurosci; 2007 Sep; 27(37):9826-34. PubMed ID: 17855597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
    Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
    Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA
    Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in motor behavior, neuropathology, and gut microbiota of a Batten disease mouse model following administration of acidified drinking water.
    Johnson TB; Langin LM; Zhao J; Weimer JM; Pearce DA; Kovács AD
    Sci Rep; 2019 Oct; 9(1):14962. PubMed ID: 31628420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.